PRINCETON, N.J. & BETHLEHEM, Pa.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Saladax Biomedical, Inc., announced today they have expanded their multi-year agreement covering the development and commercialization of diagnostic assays for the early detection of Alzheimer’s disease to include Ortho-Clinical Diagnostics, Inc.
